FourThought Financial’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$252K Sell
6,635
-826
-11% -$36.8K 0.04% 268
2022
Q2
$373K Sell
7,461
-1,511
-17% -$80.2K 0.05% 223
2022
Q1
$458K Buy
8,972
+377
+4% +$19.5K 0.06% 211
2021
Q4
$431K Buy
8,595
+303
+4% +$15K 0.05% 222
2021
Q3
$399K Buy
8,292
+1,028
+14% +$52.3K 0.05% 233
2021
Q2
$382K Buy
7,264
+2,248
+45% +$117K 0.05% 254
2021
Q1
$248K Buy
5,016
+27
+0.5% +$1.3K 0.04% 318
2020
Q4
$242K Buy
+4,989
New +$246K 0.04% 307

Other funds holding SNY

FourThought Financial's SNY Position: Q3 2022 in Review

FourThought Financial reduced its Sanofi (SNY) stake by 11% in Q3 2022, selling an estimated $36.8K and leaving 6,635 shares worth $252K. The position accounts for 0.04% of the portfolio, ranked #268.

FourThought Financial first reported a position in SNY in Q4 2020 and has held it in 8 quarters since. The position peaked at $458K in Q1 2022. 588 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • FourThought Financial held 6,635 shares of Sanofi worth $252K as of Q3 2022.
  • FourThought Financial sold 826 Sanofi shares in Q3 2022, an estimated $36.8K.
  • Sanofi made up 0.04% of FourThought Financial's portfolio in Q3 2022, its #268 holding.
  • FourThought Financial first reported a position in Sanofi in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's Sanofi position peaked at $458K in Q1 2022.
  • 588 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.